Is 1P-LSD legal in Austria?

Legal status

Controlled in Austria under the new psychoactive substances regime, and not as a narcotic or a psychotrope. The placement is group 11 of the NPS regulation's structural annexes: the official structural illustrations to the new psychoactive substances regulation name 1-Propionyl-Lysergsäurediethylamid, 1P-LSD. Its N1 propionyl substitution fits the ergoline carboxamide core in group 11 of Annex II, and the named illustration is evidence of that fit rather than a listing carrying operative words of its own. The Act's own requirements still have to be met: synthetic manufacture under NPSG §1, the medicinal channel exclusion in NPSG §2, and the conduct and intent elements of §4. NPSG §3(2) authorises the Minister to define chemical substance classes where that is better suited than naming individual substances, and NPSV §1(1) includes both Annex I's named substances and every substance encompassed by Annex II's chemical definitions, with §1(2) enumerating the permitted substituent structures and Annex III illustrating rather than exhausting the groups. A structural overlap does not create simultaneous narcotics and NPS liability: the Suchtmittelgesetz is applied first and this regime only reaches what the SMG does not.

Consequences if caught

Capital exposure: none. The Austrian NPS Act tops out at ten years under NPSG §4(2), and only where the §4(1) offence has caused a death or serious injuries to a larger number of people. No life term sits above that, and the death penalty does not exist in Austria. 1P-LSD is an NPS and not a narcotic, so it carries a very much lower ceiling than the LSD it is a prodrug of. The base offence in NPSG §4(1) allows two years, and it is emphatically not a possession offence: it requires an intention to obtain an advantage, the production, import, export, transfer or procurement conduct, and the intent that the other person or a third party use the substance to achieve a psychoactive effect in the human body. Mere possession is absent from it. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. This row is placed outside that regime, so they are recorded as Austria's published drug penalties and not as this substance's exposure.

If prescribed or medical

The rule that governs every traveller in Austria is SMG §5(1). It confines the acquisition, possession, production, processing, carriage, import, export, offering, transfer and procurement of a Suchtmittel to medical, dental, veterinary and scientific purposes, and the particular travel, licensing and dispensing provisions operate inside it rather than around it. Because this substance is reached by the new psychoactive substances regime rather than by the narcotics or psychotrope lists, neither the SMG §30(3) medicine exception nor the psychotrope travel certificate applies to it. NPSG §2 excludes lawful medicinal channels from that regime, which is a carve out for products that already hold a medicinal authorisation and not a route a traveller can claim for themselves. The practical point is the one the ceiling turns on: 1P-LSD is answered by the NPS instrument while the LSD it relates to is a named narcotic, so the two are not interchangeable at a border any more than they are in the annexes.

Documentation

Carry nothing under a prescription heading for this, because the material read establishes no Austrian medicinal authorisation and the NPS regime has no dispensing channel of its own. 1P-LSD and LSD sit in different instruments with different ceilings, so do not read the LSD row across to it. The NPS structural annexes were read at their 18 September 2026 consolidation, with Annexes II and III last amended by BGBl II 106/2024 of 18 April 2024 and Annex I last amended by BGBl II 168/2019.

Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with Austria’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.